Gareeva, A. E., Borodina, L. S., Pozdnyakov, S. A., & Timerbulatov, I. F. (2024). Pharmacogenomic and Pharmacometabolomic Biomarkers of the Efficacy and Safety of Antidepressants: Focus on Selective Serotonin Reuptake Inhibitors. Neuroscience & Behavioral Physiology, 54(8), 1205. https://doi.org/10.1007/s11055-024-01716-5
Chicago Style (17th ed.) CitationGareeva, A. E., L. S. Borodina, S. A. Pozdnyakov, and I. F. Timerbulatov. "Pharmacogenomic and Pharmacometabolomic Biomarkers of the Efficacy and Safety of Antidepressants: Focus on Selective Serotonin Reuptake Inhibitors." Neuroscience & Behavioral Physiology 54, no. 8 (2024): 1205. https://doi.org/10.1007/s11055-024-01716-5.
MLA (9th ed.) CitationGareeva, A. E., et al. "Pharmacogenomic and Pharmacometabolomic Biomarkers of the Efficacy and Safety of Antidepressants: Focus on Selective Serotonin Reuptake Inhibitors." Neuroscience & Behavioral Physiology, vol. 54, no. 8, 2024, p. 1205, https://doi.org/10.1007/s11055-024-01716-5.